Kai Liu

ORCID: 0000-0002-6947-6758
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer-related molecular mechanisms research
  • Cervical Cancer and HPV Research
  • Circular RNAs in diseases
  • Congenital Ear and Nasal Anomalies
  • Salivary Gland Tumors Diagnosis and Treatment
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • interferon and immune responses
  • Photodynamic Therapy Research Studies
  • Viral Infections and Vectors
  • Bladder and Urothelial Cancer Treatments
  • Nanoplatforms for cancer theranostics
  • RNA modifications and cancer
  • MicroRNA in disease regulation
  • Infectious Diseases and Mycology
  • Cytokine Signaling Pathways and Interactions
  • Ear and Head Tumors

Nanjing Medical University
2023-2025

ABSTRACT Recurrent respiratory papillomatosis (RRP) is a rare benign tumor caused mainly by the infection of tract epithelial cells human papillomavirus (HPV) type 6/11. However, specific mechanisms underlying inhibition host’s innate immune response HPV remain unclear. For this purpose, we employed single-cell RNA sequencing to analyze states various in RRP samples post-HPV and utilized cellular model elucidate which evades system RRP. The results revealed distinct cell heterogeneity...

10.1128/jvi.01925-23 article EN Journal of Virology 2024-04-16

Abstract Objectives Recurrent respiratory papillomatosis (RRP) is the most common benign laryngeal tumor in children. It can cause serious psychological and mental burden on patients since RRP requires repeated surgical treatment. This study aims to delineate global trends identify hotspots related over past two decades. Methods We systematically gathered research findings from 2004 2023, utilizing Web of Science as our data source. Subsequently, we performed a comprehensive bibliometric...

10.1002/lio2.1271 article EN cc-by-nc-nd Laryngoscope Investigative Otolaryngology 2024-06-01

To develop and validate a novel method for quantifying the efficacy of Bevacizumab (Bev) in treating Recurrent Respiratory Papillomatosis (RRP), to evaluate clinical outcomes three-dose Bev induction therapy followed by surgical intervention.

10.1002/lary.31706 article EN The Laryngoscope 2024-08-29

The article reported a novel reduction device and standardized technique for patients with arytenoid dislocation. results showed that this has been excellent in helping Laryngoscope, 2023

10.1002/lary.30999 article EN The Laryngoscope 2023-08-26
Coming Soon ...